newsfilter
← Latest News
GlobeNewswire·

The Australian Natural Therapeutics Group Signs a US$7.8M Product Agreement With Clever Leaves to Accelerate Medical Cannabis Access in Australia

BOCA RATON, Fla. and SYDNEY, Australia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW))) ("Clever Leaves" or the "Company"), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids